Home/Filings/4/0001127602-14-004273
4//SEC Filing

Life Technologies Corp 4

Accession 0001127602-14-004273

CIK 0001073431operating

Filed

Feb 3, 7:00 PM ET

Accepted

Feb 4, 2:58 PM ET

Size

52.6 KB

Accession

0001127602-14-004273

Insider Transaction Report

Form 4
Period: 2014-02-03
COTTINGHAM JOHN A
SVP, Chief Legal Officer
Transactions
  • Disposition to Issuer

    Common Stock

    2014-02-03$76.13/sh20,248$1,541,5050 total(indirect: By Trust)
  • Disposition to Issuer

    Stock Options

    2014-02-03$38.43/sh2,602$99,9950 total
    Exercise: $38.43From: 2006-05-13Exp: 2015-05-13Common Stock (2,602 underlying)
  • Disposition to Issuer

    Stock Options

    2014-02-03$22.23/sh74,224$1,650,0000 total
    Exercise: $22.23From: 2012-11-21Exp: 2018-11-21Common Stock (74,224 underlying)
  • Disposition to Issuer

    Restricted Stock Units

    2014-02-035,6290 total
    From: 2012-04-01Exp: 2021-04-01Common Stock (5,629 underlying)
  • Disposition to Issuer

    Common Stock

    2014-02-03$76.13/sh8,231$626,6360 total
  • Disposition to Issuer

    Stock Options

    2014-02-03$48.91/sh21,337$1,043,5930 total
    Exercise: $48.91From: 2013-04-02Exp: 2022-04-02Common Stock (21,337 underlying)
  • Disposition to Issuer

    Common Stock

    2014-02-03$76.13/sh12,232.3$931,2600 total(indirect: By Trust)
  • Disposition to Issuer

    Stock Options

    2014-02-03$32.94/sh3,036$100,0060 total
    Exercise: $32.94From: 2007-05-12Exp: 2016-05-12Common Stock (3,036 underlying)
  • Disposition to Issuer

    Stock Options

    2014-02-03$32.69/sh3,058$99,9660 total
    Exercise: $32.69From: 2005-05-14Exp: 2014-05-15Common Stock (3,058 underlying)
  • Disposition to Issuer

    Stock Options

    2014-02-03$32.69/sh26,942$880,7340 total
    Exercise: $32.69From: 2005-05-15Exp: 2014-05-14Common Stock (26,942 underlying)
  • Disposition to Issuer

    Stock Options

    2014-02-03$31.26/sh22,400$700,2240 total
    Exercise: $31.26From: 2005-11-12Exp: 2014-11-12Common Stock (22,400 underlying)
  • Disposition to Issuer

    Restricted Stock Units

    2014-02-039,2920 total
    From: 2014-04-01Exp: 2017-04-03Common Stock (9,292 underlying)
  • Disposition to Issuer

    Restricted Stock Units

    2014-02-033,0676,133 total
    From: 2013-04-02Exp: 2016-04-04Common Stock (3,067 underlying)
  • Disposition to Issuer

    Restricted Stock Units

    2014-02-036,1330 total
    From: 2013-04-02Exp: 2016-04-04Common Stock (6,133 underlying)
  • Disposition to Issuer

    Restricted Stock

    2014-02-031,137.910 total
    From: 2014-03-11Exp: 2021-03-11Common Stock (1,137.91 underlying)
  • Disposition to Issuer

    Restricted Stock Units

    2014-02-035,6295,629 total
    From: 2012-04-01Exp: 2021-04-01Common Stock (5,629 underlying)
  • Disposition to Issuer

    Restricted Stock

    2014-02-031,285.430 total
    From: 2014-01-07Exp: 2017-01-07Common Stock (1,285.43 underlying)
  • Disposition to Issuer

    Stock Options

    2014-02-03$52.00/sh40,567$2,109,4840 total
    Exercise: $52.00From: 2011-03-01Exp: 2020-03-01Common Stock (40,567 underlying)
  • Disposition to Issuer

    Stock Options

    2014-02-03$46.85/sh26,894$1,259,9840 total
    Exercise: $46.85From: 2009-05-15Exp: 2018-05-15Common Stock (26,894 underlying)
  • Disposition to Issuer

    Stock Options

    2014-02-03$38.43/sh15,398$591,7450 total
    Exercise: $38.43From: 2006-05-13Exp: 2015-05-13Common Stock (15,398 underlying)
  • Disposition to Issuer

    Stock Options

    2014-02-03$35.87/sh52,000$1,865,2400 total
    Exercise: $35.87From: 2008-05-15Exp: 2017-05-15Common Stock (52,000 underlying)
  • Disposition to Issuer

    Stock Options

    2014-02-03$32.94/sh42,964$1,415,2340 total
    Exercise: $32.94From: 2007-05-12Exp: 2016-05-12Common Stock (42,964 underlying)
  • Disposition to Issuer

    Stock Options

    2014-02-03$32.26/sh18,000$580,6800 total
    Exercise: $32.26From: 2006-11-14Exp: 2015-11-14Common Stock (18,000 underlying)
Footnotes (6)
  • [F1]On February 3, 2014, Thermo Fisher Scientific Inc., a Delaware corporation ("Thermo Fisher"), acquired the issuer pursuant to that certain merger agreement between issuer, Thermo Fisher and Polpis Merger Sub Co., a Delaware corporation and wholly owned subsidiary of Thermo Fisher ("Merger Sub"), dated as of April 14, 2013 (the "Merger Agreement"). In accordance with the Merger Agreement, Merger Sub merged with and into the issuer (the "Merger"), with the issuer surviving the Merger as a wholly owned subsidiary of Thermo Fisher. At the effective time of the Merger, each outstanding share of the issuer's common stock was converted into the right to receive $$76.1311786 in cash (the "per-share merger consideration"). In addition, all outstanding options, performance restricted stock units and service-based restricted stock units were canceled at the effective time of the Merger in exchange for a cash payment equal to the per-share merger consideration (less the exercise price in the case of options), payable without interest and less any required withholding taxes (other than certain service-based restricted stock units that were assumed by Thermo Fisher at the effective time of the Merger and converted into the right to receive a cash payment equal to the per-share merger consideration, which will vest and become payable following the effective time of the Merger in accordance with their original terms). The Merger is more fully described in the issuer's Proxy Statement filed with the SEC on July 22, 2013.
  • [F2]Common stock issued under Deferred Compensation Plan.
  • [F3]These Stock Options, which provided for vesting in four equal annual installments beginning on the first anniversary of the date of the grant, were canceled at the effective time of the Merger (whether vested or unvested) in exchange for a cash payment equal to the per-share merger consideration, less the exercise price of the option.
  • [F4]These service-based Restricted Stock Units, which provided for vesting in four equal annual installments beginning on the first anniversary of the date of the grant, were canceled at the effective time of the Merger in exchange for a cash payment equal to the per-share merger consideration.
  • [F5]These service-based Restricted Stock Units, which provided for vesting in four equal annual installments beginning on the first anniversary of the date of the grant, were assumed by Thermo Fisher at the effective time of the Merger and converted into the right to receive a cash payment equal to the per-share merger consideration, which will vest and become payable following the effective time of the Merger in accordance with their original terms.
  • [F6]These service-based Restricted Stock Units, which were issued under the Deferred Compensation Plan matching program and provided for vesting on the third anniversary of the time the match was made, were canceled at the effective time of the Merger in exchange for a cash payment equal to the per-share merger consideration.

Issuer

Life Technologies Corp

CIK 0001073431

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001073431

Filing Metadata

Form type
4
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 2:58 PM ET
Size
52.6 KB